SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000929638-23-000423
Filing Date
2023-02-13
Accepted
2023-02-13 16:37:50
Documents
2
Group Members
JEFF EASTONLIND GLOBAL PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 (AMENDMENT NO. 1)* sc13ga.htm SC 13G 72347
2 JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS exhibit99-1.htm EX-99.1 7742
  Complete submission text file 0000929638-23-000423.txt   81754
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88748 | Film No.: 23619153
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 MADISON AVE, FLOOR 41 NEW YORK NY 10022
Business Address 444 MADISON AVE, FLOOR 41 NEW YORK NY 10022 646-395-3931
Lind Global Macro Fund LP (Filed by) CIK: 0001773156 (see all company filings)

IRS No.: 830854952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G